Evidence map›Paper›PMID 19305390›Full record

ReviewEMBO reports2009

Revisiting the COP9 signalosome as a transcriptional regulator.

Daniel A Chamovitz

Open access · bronzeAbstract readReview
In one paragraph

Review in EMBO reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 102 citations in OpenAlex.

  1. COP9 Signalosome's Role in Plant Defense Mechanisms.Plants (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A novel small open reading frame gene,Frontiers in plant science · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Cops5 safeguards genomic stability of embryonic stem cells through regulating cellular metabolism and DNA repair.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel A ChamovitzDepartment of Plant Sciences, Tel Aviv University, Tel Aviv 69978, Israel. dannyc@tauex.tau.ac.il
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COP9 signalosome (CSN) is a highly conserved protein complex that was originally described as a repressor of light-dependent growth and transcription in Arabidopsis. The most studied CSN function is the regulation of protein degradation, which occurs primarily through the removal of the ubiquitin-like modifier Nedd8 from cullin-based E3 ubiquitin ligases. This activity can regulate transcription-factor stability and, therefore, transcriptional activity. Recent data suggest that the CSN also regulates transcription on the chromatin by mechanisms that are not yet clearly understood. Furthermore, the CSN subunits CSN5 and CSN2 seem to act as transcriptional coactivators and corepressors, respectively. Here, I re-evaluate the mechanisms by which the CSN acts as a transcriptional regulator, and suggest that they could extend beyond the regulation of protein stability.

Indexed as

Arabidopsis ProteinsCOP9 Signalosome ComplexModels, BiologicalMultiprotein ComplexesPeptide HydrolasesTranscription, GeneticArabidopsis ProteinsCOP9 Signalosome ComplexCOP9 signalosome subunit 5, ArabidopsisMultiprotein ComplexesPeptide Hydrolases

Identifiers

PMID19305390
PMCPMC2672896
OpenAlexW1991901937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.